A CASE REPORT ON PHENYTOIN INDUCED ATAXIA

  • Sangram Vurumadla St.Peters Institute of Pharmaceutical sciences
  • Jyothsna Rani Dasari
  • Om Prakash Prasad

Abstract

ABSTRACT
Phenytoin is commonly used anticonvulsant drug which has several adverse effects such as motor ataxia, dizziness, and visual disturbance. Here,
we report a case of phenytoin toxicity presenting with behavioral disorder ensuring from underlying primary adverse effects of phenytoin that were
clinically unnoted. A termination of phenytoin resulted in remission of side effects.
Keywords: Phenytoin toxicity, Anticonvulsant drug, Behavioral disorder.

References

REFERENCES
1. Browne TR. Phenytoin and other hydantoins. In: Engel J Jr, Pedley TA,
editors. Epilepsy: A Comprehensive Textbook. Philadelphia, PA:
Lippincott – Raven; 1987. p. 1557-79.
2. Iivanainen M, Savolainen H. Side effects of phenobarbital and
phenytoin during long-term treatment of epilepsy. Acta Neurol Scand
Suppl 1983;97:49-67.
3. Larsen JR, Larsen LS. Clinical features and management of poisoning
due to phenytoin. Med Toxicol Adverse Drug Exp 1989;4(4):229-45.
4. Cohen AF, Ashby L, Crowley D, Land G, Peck AW, Miller AA.
Lamotrigine (BW430C), a potential anticonvulsant. Effects on the
central nervous system in comparison with phenytoin and diazepam. Br
J Clin Pharmacol 1985;20(6):619-29.
5. Madhusudan Singh S, Kuldip K. Usual erratic phenomenon, dramatic
outcome: A case report of phenytoin toxicity. Bull Clin Psychopharmacol
2013;23(1):81-3.
6. Tolosa E, Alom I, Marti MJ. Drug-induced dyskinesias. In: Jankovic J,
Tolosa E, editors. Parkinson’s Disease and Movement Disorders. 2
ed.
Baltimore: Williams and Wilkins; 1992. p. 375-97.
7. Chadwick D, Reynolds EH, Marsden CD. Anticonvulsant-induced
dyskinesias: A comparison with dyskinesias induced by neuroleptics.
J Neurol Neurosurg Psychiatry 1976;39(12):1210-8.
8. Duarte J, Sempere AP, Cabezas MC, Marcos J, Clavería LE.
Postural myoclonus induced by phenytoin. Clin Neuropharmacol
1996;19(6):536-8.
9. Filloux F, Thompson JA. Transient chorea induced by phenytoin.
J Pediatr 1987;110(4):639-41.
10. Buchthal F, Svensmark O, Schiller PJ. Clinical and
electroencephalographic correlations with serum levels of
diphenylhydanotin. Arch Neurol 1960;2:624-30.
11. Kokenge R, Kutt H, Mcdowell F. Neurological sequelae following
dilantin overdose in a patient and in experimental animals. Neurology
1965;15:823-9.
12. Ghatak NR, Santoso RA, McKinney WM. Cerebellar degeneration
following long-term phenytoin therapy. Neurology 1976;26(9):818-20.
13. Ney GC, Lantos G, Barr WB, Schaul N. Cerebellar atrophy in
patients with long-term phenytoin exposure and epilepsy. Arch Neurol
1994;51(8):767-71.
14. Hussein A, Abdulgalil A, Omer F, Eltoum H, Hamad A, El-Adil O,
et al. Correlation between serum level of antiepileptic drugs and their
side effects. Oman Med J 2010;25(1):17-21.
15. Lüders H, Acharya J, Baumgartner C, Benbadis S, Bleasel A,
Burgess R, et al. Semiological seizure classification. Epilepsia
1998;39(9):1006-13.
Statistics
305 Views | 0 Downloads
How to Cite
Vurumadla, S., J. Dasari, and O. Prasad. “A CASE REPORT ON PHENYTOIN INDUCED ATAXIA”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 9, no. 4, July 2016, pp. 5-6, https://innovareacademics.in/journals/index.php/ajpcr/article/view/12059.
Section
Case Study(s)